CD56bright NK cells in elderly CML patients showed a decreased expression of HLA-DR (measured as MFI) and a reduction in the percentage of CD69 and NKp44 positive cells compared with elderly healthy donors. This evidence concerns the gene CD69 and chronic myelogenous leukemia, BCR-ABL1 positive.